Dailypharm Live Search Close

Expanding the submission of opinions reflecting permission

By Lee, Tak-Sun | translator Choi HeeYoung

21.10.06 15:44:19

°¡³ª´Ù¶ó 0
Add a pre-announcement procedure for 14 days to classify the Adverse effect analysis results



Opportunities for submitting opinions from industries will be expanded when reflecting permits based on the results of the reexamination. A pre-announcement procedure is added to the previous opinion inquiry.

The MFDS announced that since the 27th of last month, the procedure for reflecting permits based on the results of the reexamination has been improved and applied. There was a 14-day period of submitting opinions through "Inquiry on Opinions on Permit Change" before reflecting the results of the retrial in the permission. An opportunity to submit opinions will be given one more time.

An official from the MFDS said, "It is expected that opportunities for the industry to submit opinion

Lee, Tak-Sun(hooggasi2@dailypharm.com)
If you want to see the full article, please JOIN US (click)